Over 22.75 crore vaccines registered against COVID-19 till 140th day of inoculation drive: Centre

Of the total, nearly 2.59 crore beneficiaries in the 18-44 age bracket received their first dose and 1,18,299 their second dose since 1 May

Press Trust of India June 04, 2021 23:42:30 IST
Over 22.75 crore vaccines registered against COVID-19 till 140th day of inoculation drive: Centre

Representational image. AP

New Delhi: The cumulative number of COVID-19 vaccine doses administered in the country has crossed 22.75 crore, with 33,57,713 doses being administered Friday, the Union health ministry said.

It said 16,23,602 beneficiaries in the age group 18-44 years received their first dose and 31,217 in the same category their second dose on Friday.

Cumulatively, 2,58,45,901 people in the age group across 36 states and union territories have received their first dose and 1,18,299 their second dose since the vaccination drive began for them from 1 May.

Bihar, Delhi, Gujarat, Haryana, Karnataka, Madhya Pradesh, Maharashtra, Rajasthan, Tamil Nadu, Uttar Pradesh and West Bengal have administered more than 10 lakh beneficiaries of the age group 18-44 years for the first dose, the ministry said.

The total of 22,75,67,873 include 99,44,507 healthcare workers (HCWs) who have taken the first dose and 68,40,415 HCWs who have taken the second dose.

It also includes 1,60,45,747 frontline workers (FLWs) who have received the first dose and 86,34,525 FLWs who have taken the second dose.

As many as 2,58,45,901 and 1,18,299 individuals in the 18-44 years age group have received the first and second dose respectively.

Besides, 6,96,94,235 and 1,11,86,697 beneficiaries aged over 45 to 60 years old have been administered the first and second dose respectively.

As many as 6,01,48,354 and 1,91,09,193 beneficiaries above 60 years have taken the first and second dose.

As on the 140th day of the vaccination drive (4 June), a total of 33,57,713 vaccine doses were given, the ministry said.

It said 31,01,109 beneficiaries were vaccinated for their first doses and 2,56,604 beneficiaries their second dose, according to the provisional report till 7 pm.

Final reports would be completed for the day by late night.

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level, the ministry underlined.

Updated Date:

also read

Black fungus: From symptoms to causes of infection, here are key facts about the disease
India

Black fungus: From symptoms to causes of infection, here are key facts about the disease

Black Fungus: Who is at high risk? What should you do if you experience symptoms? How Black Fungus spreads, Signs, symptoms to causes of infection, everything you need to know about it

Black Fungus: 11,717 cases reported till now; Centre allocates 29,250 more Amphotericin-B vials to states, UTs
India

Black Fungus: 11,717 cases reported till now; Centre allocates 29,250 more Amphotericin-B vials to states, UTs

The government has allocated 7,210 vials to Gujarat, followed by 6,980 vials to Maharashtra. Both the states have logged the highest number of Mucormycosis infections so far

Black Fungus: India receives 50,000 Amphotericin-B vials from US pharma firms
India

Black Fungus: India receives 50,000 Amphotericin-B vials from US pharma firms

US-based pharma firms like Gilead Sciences and Mylan have sent 50,000 vials of anti-black fungus medicine, said MoS for Chemicals and Fertilisers Mansukh L Mandaviya on Friday